References
- Ahn, S. I., Lim, S. J., Gu, G. J., Hong, C. Y., Kim, J. S., Jeong, H. J., … Youn, H. S. (2015). Suppressive effects of 1-[4-fluoro-2-(2-nitrovinyl)phenyl]pyrrolidine on the Toll-like receptor signaling pathways. International Immunopharmacology, 24(1), 36–41. doi: 10.1016/j.intimp.2014.10.033
- Baldwin, A. S., Jr. (1996). The NF-kappa B and I kappa B proteins: New discoveries and insights. Annual Review of Immunology, 14, 649–683. doi: 10.1146/annurev.immunol.14.1.649
- Gu, G. J., Ahn, S. I., Kim, J. S., Hong, C. Y., Lee, S. C., Chang, Y. T., … Youn, H. S. (2015). Suppression of the TRIF-dependent signaling pathway of Toll-like receptor by CDr10b in RAW264.7 macrophages. International Immunopharmacology, 28(1), 29–33. doi: 10.1016/j.intimp.2015.05.017
- Gu, G. J., Lim, S. J., Ahn, S. I., Lee, S. C., Chang, Y. T., Choi, T. H., … Youn, H. S. (2014). CDr10b inhibits the expression of cyclooxygenase-2 and inducible nitric oxide synthase induced by lipopolysaccharide. European Journal of Pharmacology, 742, 42–46. doi: 10.1016/j.ejphar.2014.08.036
- Hacker, H., & Karin, M. (2006). Regulation and function of IKK and IKK-related kinases. Science's STKE, 2006(357), re13. doi: 10.1126/stke.3572006re13
- Kim, A. R., Jin, Q., Jin, H. G., Ko, H. J., & Woo, E. R. (2014). Phenolic compounds with IL-6 inhibitory activity from Aster yomena. Archives of Pharmacal Research, 37(7), 845–851. doi: 10.1007/s12272-013-0236-x
- Lee, E. K., Jeong, D. W., Lim, S. J., Gu, G. J., Ahn, S. I., Kim, J. S., … Youn, H. S. (2014). Carpesium abrotanoides extract inhibits inducible nitric oxide synthase expression induced by Toll-like receptor agonists. Food Science and Biotechnology, 23(5), 1637–1641. doi: 10.1007/s10068-014-0223-0
- Moncada, S. (1999). Nitric oxide: Discovery and impact on clinical medicine. Journal of the Royal Society of Medicine, 92(4), 164–169.
- Murakami, A., & Ohigashi, H. (2007). Targeting NOX, INOS and COX-2 in inflammatory cells: Chemoprevention using food phytochemicals. International Journal of Cancer, 121(11), 2357–2363. doi: 10.1002/ijc.23161
- Murakami, A., Takahashi, D., Koshimizu, K., & Ohigashi, H. (2003). Synergistic suppression of superoxide and nitric oxide generation from inflammatory cells by combined food factors. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 523–524, 151–161. doi: 10.1016/S0027-5107(02)00331-7
- Park, H. J., & Youn, H. S. (2013). Mercury induces the expression of cyclooxygenase-2 and inducible nitric oxide synthase. Toxicology and Industrial Health, 29(2), 169–174. doi: 10.1177/0748233711427048
- Park, M. Y. (2015). Carnosic acid disrupts Toll-like receptor 2 signaling pathway in Pam3CSK4-stimulated macrophages. Toxicology and Environmental Health Sciences, 7(3), 224–230. doi: 10.1007/s13530-015-0242-0
- Rouzer, C. A., & Marnett, L. J. (2009). Cyclooxygenases: Structural and functional insights. The Journal of Lipid Research, 50, S29–S34. doi: 10.1194/jlr.R800042-JLR200
- Shin, H. J., Shon, D. H., & Youn, H. S. (2013). Isobavachalcone suppresses expression of inducible nitric oxide synthase induced by Toll-like receptor agonists. International Immunopharmacology, 15(1), 38–41. doi: 10.1016/j.intimp.2012.11.005
- Sim, J. H., Lee, H. S., Lee, S., Park, D. E., Oh, K., Hwang, K. A., … Kim, H. R. (2014). Anti-asthmatic activities of an ethanol extract of Aster yomena in an ovalbumin-induced murine asthma model. Journal of Medicinal Food, 17(5), 606–611. doi: 10.1089/jmf.2013.2939
- Surh, Y. J., Chun, K. S., Cha, H. H., Han, S. S., Keum, Y. S., Park, K. K., & Lee, S. S. (2001). Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 480–481, 243–268. doi: 10.1016/S0027-5107(01)00183-X
- Turini, M. E., & Dubois, R. N. (2002). Cyclooxygenase-2: A therapeutic target. Annual Review of Medicine, 53, 35–57. doi: 10.1146/annurev.med.53.082901.103952
- Vane, J. R. (1971). Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biology, 231(25), 232–235. doi: 10.1038/newbio231232a0